OurBrainBank Wins Forbes EQ BrandVoice 2024: First Article Features Jessica Morris’s book
OBB founder Jessica Morris’s book is excerpted by Forbes.
Read more
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
White House Cancer Moonshot
OurBrainBank is proud that the White House invited us to be part of the ambitious Cancer Moonshot effort. Read the latest from Washington DC.
OurBrainBank at SNO — Society for Neuro-Oncology — Annual Conference
Executive Director Kelli Duprey presented our poster about treatment disparities at SNO 2023
Clinical trial for people newly diagnosed with glioblastoma
Clinical trial for people newly diagnosed with glioblastoma
Stanford Researchers look to Artificial Intelligence to help plan GBM treatment
Model could help doctors identify patients with cellular characteristics that indicate more aggressive tumors, and flag them for accelerated follow-up.
May is Brain Tumor Awareness Month
MAY is Brain Tumor Awareness Month: give, share, raise awareness about glioblastoma
Join us on June 5, 2025 for a celebration of ALL IN MY HEAD, by Jessica Morris, Brooklyn
Join us on June 5, 2025 in Brooklyn to celebrate Jessica Morris’s memoir of living with glioblastoma ALL IN MY HEAD. Readings and conversation with a GBM care partner and a top neuro-oncologist from Columbia University.
Conductor Michael Tilson Thomas stepping back due to a recurrence
Read the letter conductor Michael Tilson Thomas posted. He’s has been open about his glioblastoma diagnosis with his many fans around the world.
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
